how do glp-1 receptor agonists work Trends in the Development of Frontiers | GLP−1 receptor agonists

Since GLP-1RA therapy reduces energy intake primarily through appetite suppression, and observational studies suggest that dietary protein intake may also decline during treatment [75]

2024;385:e078225

Any concerning symptomsincluding severe gastrointestinal distress, allergic reactions, chest pain, or neurological changeswarrant immediate medical evaluation and discontinuation of the product

27 Importantly, GLP-1 action is short-lived, with a half-life of just 12 minutes in the bloodstream under normal physiological conditions, after which it is broken down by the enzyme dipeptidyl peptidase IV (DPP-4), resulting in a loss of its biological activity

Studying pancreatic risks caused by incretin-based therapies: Is it a game